|
WO1998004569A1
(en)
*
|
1996-07-26 |
1998-02-05 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
BR9811552A
(pt)
*
|
1997-07-25 |
2000-08-29 |
Gilead Sciences Inc |
Composições de análogos de nucleotìdeos
|
|
DK1243590T3
(da)
*
|
1997-07-25 |
2005-07-25 |
Gilead Sciences Inc |
Nukleotid-analog sammensætning og syntesemetode
|
|
ATE288914T1
(de)
*
|
1997-07-25 |
2005-02-15 |
Gilead Sciences Inc |
Nukleotid-analog zusamensetzung und synthese verfahren
|
|
BR9911457A
(pt)
*
|
1998-06-24 |
2001-12-11 |
Univ Emory |
Uso de 3'-azida-2', 3'-dideoxiuridina em combinaçãocom drogas anti-hiv adicionais para a manufaturade um medicamento para o tratamento de hiv
|
|
AP1466A
(en)
*
|
2000-07-21 |
2005-09-22 |
Gilead Sciences Inc |
Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same.
|
|
UA80819C2
(en)
|
2002-04-26 |
2007-11-12 |
Gilead Sciences Inc |
Phosphonate analogs of compounds inhibiting hiv proteases, pharmaceutical composition on their basis and their use
|
|
KR20090053867A
(ko)
|
2003-01-14 |
2009-05-27 |
길리애드 사이언시즈, 인코포레이티드 |
복합 항바이러스 치료를 위한 조성물 및 방법
|
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
AU2004233897A1
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
SG182849A1
(en)
|
2003-04-25 |
2012-08-30 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
US7300924B2
(en)
|
2003-04-25 |
2007-11-27 |
Gilead Sciences, Inc. |
Anti-infective phosphonate analogs
|
|
EA011948B1
(ru)
|
2003-06-16 |
2009-06-30 |
Инститьют Оф Оргэник Кемистри Энд Байокемистри, Экэдеми Оф Сайэнс Оф Зе Чек Рипаблик |
Фосфонатзамещенные пиримидиновые соединения (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции
|
|
US7432273B2
(en)
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
JP2007508845A
(ja)
|
2003-10-24 |
2007-04-12 |
ギリアード サイエンシーズ， インコーポレイテッド |
治療用化合物の同定のための方法および組成物
|
|
WO2005044279A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
EP1715871A1
(en)
*
|
2003-12-22 |
2006-11-02 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
ATE424400T1
(de)
|
2003-12-22 |
2009-03-15 |
Gilead Sciences Inc |
4'-substituierte carbovir- und abacavir-derivate sowie verwandte verbindungen mit hiv- und hcv- antiviraler wirkung
|
|
TR201906416T4
(tr)
|
2004-07-27 |
2019-05-21 |
Gilead Sciences Inc |
Hiv inhibitörü bileşiklerin fosfonat analogları.
|
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
JP5323476B2
(ja)
*
|
2005-06-13 |
2013-10-23 |
博瑞生物医葯技▲術▼（▲蘇▼州）有限公司 |
ヌクレオチド類縁体プロドラッグおよびその製剤
|
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
JP5291700B2
(ja)
|
2007-04-13 |
2013-09-18 |
サザン リサーチ インスティテュート |
血管新生阻害薬及び使用方法
|
|
AU2008253803A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Ultimorphix Technolgies B.V. |
Tenofovir disoproxil hemi-fumaric acid Co-crystal
|
|
WO2009064174A1
(en)
*
|
2007-11-14 |
2009-05-22 |
Ultimorphix Technologies B.V. |
Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
|
|
NZ588796A
(en)
*
|
2008-04-25 |
2012-07-27 |
Cipla Ltd |
Crystalline form of tenofovir disoproxil and a process for its preparation
|
|
BRPI0915878A2
(pt)
|
2008-07-08 |
2015-11-03 |
Gilead Sciences Inc |
sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
|
|
CN102093422B
(zh)
|
2009-12-10 |
2015-02-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
无环核苷膦酸酯衍生物及其医药用途
|
|
BR112013028698A8
(pt)
*
|
2011-05-10 |
2018-04-03 |
Okapi Sciences Nv |
Compostos para uso no tratamento de infecções retrovirais em felinos
|
|
AU2012296622C1
(en)
|
2011-08-16 |
2017-02-16 |
Gilead Sciences, Inc. |
Tenofovir alafenamide hemifumarate
|
|
CN103626802A
(zh)
*
|
2012-08-23 |
2014-03-12 |
重庆药友制药有限责任公司 |
一种制备替诺福韦的新方法
|
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
|
JP2015536940A
(ja)
|
2012-10-29 |
2015-12-24 |
シプラ・リミテッド |
抗ウイルス性ホスホネート類似体及びその製造方法
|
|
EP2860185A1
(en)
|
2013-10-09 |
2015-04-15 |
Zentiva, k.s. |
An improved process for the preparation of Tenofovir disoproxil and pharmaceutically acceptable salts thereof
|
|
EP2860184B1
(en)
|
2013-10-09 |
2018-08-29 |
Zentiva, k.s. |
Dihydrogenphosphate salt of Tenofovir disoproxil
|
|
TWI660965B
(zh)
*
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
泰諾福韋之固體形式
|
|
SI3661937T1
(sl)
|
2017-08-01 |
2021-11-30 |
Gilead Sciences, Inc. |
Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
|
|
CN107805202A
(zh)
*
|
2017-12-01 |
2018-03-16 |
内蒙古圣氏化学股份有限公司 |
一种氯甲基异丙基碳酸酯连续化反应装置及方法
|